Thomas M. Ross Maxcyte, Inc. (MXCT) insider trading activity

MXCT Quotes by TradingView

Thomas M. Ross is EVP, GLOBAL SALES of MAXCYTE, INC.. Currently has a direct ownership of 25,000 shares of MXCT, which is worth approximately $101,499. The most recent transaction as insider was on Aug 02, 2024, when has been sold 17,857 shares (Common Stock) at a price of $4.36 per share, resulting in proceeds of $77,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
0% 3M change
Infinity% 12M change
Total Value Held $101,499

Thomas M. Ross Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2024
SELL
Open market or private sale
$77,856 $4.36 p/Share
17,857 Reduced 41.67%
25,000 Common Stock
Aug 02 2024
BUY
Exercise of conversion of derivative security
$29,285 $1.64 p/Share
17,857 Added 29.41%
42,857 Common Stock
Aug 01 2024
SELL
Open market or private sale
$70,261 $4.54 p/Share
15,476 Reduced 38.24%
25,000 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$25,380 $1.64 p/Share
15,476 Added 27.66%
40,476 Common Stock
Jul 09 2024
SELL
Open market or private sale
$54,529 $4.03 p/Share
13,531 Reduced 35.12%
25,000 Common Stock
Jul 09 2024
BUY
Exercise of conversion of derivative security
$22,190 $1.64 p/Share
13,531 Added 25.99%
38,531 Common Stock
Jul 08 2024
SELL
Open market or private sale
$79,802 $4.03 p/Share
19,802 Reduced 44.2%
25,000 Common Stock
Jul 08 2024
BUY
Exercise of conversion of derivative security
$32,475 $1.64 p/Share
19,802 Added 30.65%
44,802 Common Stock
Jun 20 2024
SELL
Open market or private sale
$136,331 $4.09 p/Share
33,333 Reduced 57.14%
25,000 Common Stock
Jun 20 2024
BUY
Exercise of conversion of derivative security
$54,666 $1.64 p/Share
33,333 Added 36.36%
58,333 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock
Apr 12 2023
SELL
Open market or private sale
$27,915 $5.0 p/Share
5,583 Reduced 100.0%
0 Common Stock
Apr 12 2023
BUY
Exercise of conversion of derivative security
$11,947 $2.14 p/Share
5,583 Added 50.0%
5,583 Common Stock
Apr 11 2023
SELL
Open market or private sale
$42,255 $5.0 p/Share
8,451 Reduced 100.0%
0 Common Stock
Apr 11 2023
BUY
Exercise of conversion of derivative security
$18,085 $2.14 p/Share
8,451 Added 50.0%
8,451 Common Stock
Apr 10 2023
SELL
Open market or private sale
$500 $5.0 p/Share
100 Reduced 100.0%
0 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$214 $2.14 p/Share
100 Added 50.0%
100 Common Stock
Apr 06 2023
SELL
Open market or private sale
$136,780 $5.03 p/Share
27,193 Reduced 100.0%
0 Common Stock
Apr 06 2023
BUY
Exercise of conversion of derivative security
$58,193 $2.14 p/Share
27,193 Added 50.0%
27,193 Common Stock
Apr 05 2023
SELL
Open market or private sale
$34,835 $5.0 p/Share
6,967 Reduced 100.0%
0 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
$14,909 $2.14 p/Share
6,967 Added 50.0%
6,967 Common Stock
Apr 04 2023
SELL
Open market or private sale
$36,547 $5.03 p/Share
7,266 Reduced 100.0%
0 Common Stock
Apr 04 2023
BUY
Exercise of conversion of derivative security
$15,549 $2.14 p/Share
7,266 Added 50.0%
7,266 Common Stock
Apr 03 2023
SELL
Open market or private sale
$501 $5.01 p/Share
100 Reduced 100.0%
0 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$214 $2.14 p/Share
100 Added 50.0%
100 Common Stock
TMR

Thomas M. Ross

EVP, GLOBAL SALES
Gaithersburg, MD

Track Institutional and Insider Activities on MXCT

Follow MAXCYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MXCT shares.

Notify only if

Insider Trading

Get notified when an Maxcyte, Inc. insider buys or sells MXCT shares.

Notify only if

News

Receive news related to MAXCYTE, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MXCT